About the Company
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $FLXN News
Pacira (PCRX) Preliminary '23 Revenues Solid, Exparel Strong
The acquisition of Flexion Therapeutics, Inc. in November 2021 gave Pacira its second marketed product, Zilretta, which is ...
Here's Why You Should Add Pacira (PCRX) Stock to Your Portfolio
Product Acquisitions Through Strategic Collaborations, a Positive: In April 2019, Pacira acquired the privately held company, MyoScience, Inc., following ... of Flexion Therapeutics for $8.50 ...
Versant Ventures III, LLC's Net Worth
Inc., and Flexion Therapeutics Inc. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive ...
TRDA Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its EEV platform ...
TNGX Tango Therapeutics, Inc.
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein ...
Omega Therapeutics Inc OMGA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
PFIZER INC's Net Worth
PFIZER INC has an estimated net worth of $2.44 Billion. This is based on reported shares across multiple companies, which include BioAtla, Inc., Viatris Inc, Cerevel Therapeutics Holdings, Inc ...
Cara Therapeutics Inc CARA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms ...
Seres Therapeutics Inc (MCRB) Reports Encouraging Sales Growth and Strategic Cost Savings in 2023
Warning! GuruFocus has detected 8 Warning Signs with MCRB. On March 5, 2024, Seres Therapeutics Inc (NASDAQ:MCRB) released its 8-K filing, announcing the fourth quarter and full year financial ...
Monopar Therapeutics Inc
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development ...
Akero Therapeutics Inc (AKRO)
Jonathan Young, the Chief Operating Officer of Akero Therapeutics, Inc. (NASDAQ:AKRO), has recently sold shares of the company's common stock, generating over $18,000 in the... Akero Therapeutics ...
Loading the latest forecasts...